| scholarly article | Q13442814 |
| P50 | author | Christine Van Broeckhoven | Q2247235 |
| John Q. Trojanowski | Q6253636 | ||
| Peter Riederer | Q7176599 | ||
| Nenad Bogdanovic | Q96683791 | ||
| Marc Cruts | Q114375600 | ||
| Ainhoa Alzualde | Q114407906 | ||
| Jill R Murrell | Q115633756 | ||
| Rosa Rademakers | Q28777946 | ||
| Jordan Grafman | Q30112579 | ||
| Dennis W. Dickson | Q30504740 | ||
| Marsel Mesulam | Q56862907 | ||
| Bernardino F. Ghetti | Q56863342 | ||
| Eileen H Bigio | Q57020324 | ||
| Vivianna M Van Deerlin | Q59820064 | ||
| Peter Paul De Deyn | Q60327954 | ||
| Charles L White | Q60638965 | ||
| William Hu | Q64605574 | ||
| Peter Heutink | Q66718007 | ||
| Murray Grossman | Q66724764 | ||
| Marla Gearing | Q67212581 | ||
| Thomas G Beach | Q67218653 | ||
| Randall L Woltjer | Q67221637 | ||
| Nigel J Cairns | Q67234695 | ||
| Bradley F Boeve | Q67501037 | ||
| Fermin Moreno | Q88264745 | ||
| Alice S Chen-Plotkin | Q88981904 | ||
| Patrick M Sleiman | Q90743109 | ||
| Neill R Graff-Radford | Q91360658 | ||
| Kimmo Hatanpaa | Q91409013 | ||
| Gerard D Schellenberg | Q91709878 | ||
| Albert Llado Plarrumani | Q91822909 | ||
| Ronald L Hamilton | Q92023525 | ||
| Harro Seelaar | Q92438245 | ||
| Matthew Frosch | Q96050183 | ||
| Myron F. Weiner | Q37370228 | ||
| Jillian J. Kril | Q37840325 | ||
| Jonathan D Rohrer | Q42407224 | ||
| John Van Swieten | Q42684069 | ||
| William S Brooks | Q43222873 | ||
| Howard Feldman | Q44950327 | ||
| Jeffrey Kaye | Q45263160 | ||
| Glenda Halliday | Q45304807 | ||
| Maria Martinez-Lage | Q45946614 | ||
| Julie Snowden | Q50765521 | ||
| Sebastiaan Engelborghs | Q56616406 | ||
| Bruce L. Miller | Q56825815 | ||
| P2093 | author name string | Robert Greene | |
| Thomas D Bird | |||
| Ian R A Mackenzie | |||
| Salvatore Spina | |||
| Virginia M Y Lee | |||
| Elisabeth McCarty Wood | |||
| Allison Goate | |||
| Shaoxu Bing | |||
| P2860 | cites work | Isolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domains | Q24305310 |
| A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase | Q24542357 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
| Granulins, a novel class of peptide from leukocytes | Q28268552 | ||
| The epithelin precursor encodes two proteins with opposing activities on epithelial cell growth | Q28274290 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| The neuropathology and clinical phenotype of FTD with progranulin mutations | Q28299352 | ||
| Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
| Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions | Q30434949 | ||
| Primary Progressive Aphasia — A Language-Based Dementia | Q30882334 | ||
| Epithelins 1 and 2: isolation and characterization of two cysteine-rich growth-modulating proteins | Q33838997 | ||
| Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease | Q33955976 | ||
| The prevalence of frontotemporal dementia | Q33959615 | ||
| Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration | Q33978879 | ||
| Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration | Q33999208 | ||
| Characteristics of frontotemporal dementia patients with a Progranulin mutation | Q34330746 | ||
| Brain progranulin expression in GRN-associated frontotemporal lobar degeneration | Q35014879 | ||
| Prominent phenotypic variability associated with mutations in Progranulin | Q35188858 | ||
| Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies | Q35607253 | ||
| Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes | Q36227050 | ||
| Progranulin locus deletion in frontotemporal dementia | Q59698065 | ||
| Progranulin null mutations in both sporadic and familial frontotemporal dementia | Q80162804 | ||
| Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations | Q36728531 | ||
| Loss of progranulin function in frontotemporal lobar degeneration | Q37105126 | ||
| Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia | Q37260852 | ||
| Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia | Q37373937 | ||
| TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration | Q38382616 | ||
| Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair | Q40677795 | ||
| Progranulin is a mediator of the wound response | Q40678214 | ||
| Tau is a candidate gene for chromosome 17 frontotemporal dementia | Q42456776 | ||
| Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease | Q46813677 | ||
| Corticobasal syndrome associated with the A9D Progranulin mutation | Q46965357 | ||
| A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology | Q48199458 | ||
| Mutations in progranulin explain atypical phenotypes with variants in MAPT. | Q48384341 | ||
| The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene | Q48384348 | ||
| Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. | Q51970854 | ||
| Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. | Q51971909 | ||
| Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. | Q51972686 | ||
| Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. | Q51973117 | ||
| A novel deletion in progranulin gene is associated with FTDP-17 and CBS. | Q53509247 | ||
| P433 | issue | 4 | |
| P921 | main subject | frontotemporal lobar degeneration | Q18579 |
| P304 | page(s) | 488-497 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration | |
| P478 | volume | 68 |
| Q38110488 | "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide |
| Q92897630 | A Clinical Guide to Frontotemporal Dementias |
| Q39434968 | A clinicopathological approach to the diagnosis of dementia |
| Q37600861 | A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank |
| Q90593924 | AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity |
| Q34262758 | Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. |
| Q36121377 | Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program |
| Q36603819 | Asymmetric pathology in primary progressive aphasia with progranulin mutations and TDP inclusions. |
| Q28079852 | Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis |
| Q39472371 | Circulating progranulin as a biomarker for neurodegenerative diseases |
| Q38118236 | Clinical Subtypes of Frontotemporal Dementia |
| Q48346457 | Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism |
| Q36528554 | Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions |
| Q38401876 | Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations |
| Q48385958 | Dramatic impairment of prediction due to frontal lobe degeneration |
| Q44334424 | Early neuropsychological characteristics of progranulin mutation carriers |
| Q47839519 | Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family. |
| Q64046371 | Frequency of frontotemporal dementia gene variants in , , and in academic versus commercial laboratory cohorts |
| Q28081198 | Frontotemporal dementia: a bridge between dementia and neuromuscular disease |
| Q38382217 | Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype |
| Q35204586 | Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine |
| Q38040822 | Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management |
| Q38393604 | GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil. |
| Q89438455 | Genetic Modifiers in Neurodegeneration |
| Q56069696 | Genetics of dementia |
| Q38027808 | Genetics of dementia: update and guidelines for the clinician |
| Q60521494 | Genotype–phenotype links in frontotemporal lobar degeneration |
| Q26996741 | Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease |
| Q58104434 | Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers |
| Q48795615 | Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease |
| Q26829009 | Mouse models of frontotemporal dementia |
| Q38005283 | Multimodal comparative studies of neurodegenerative diseases |
| Q50532320 | Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay |
| Q50980787 | Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study |
| Q89011149 | Pathogenic Signal Sequence Mutations in Progranulin Disrupt SRP Interactions Required for mRNA Stability |
| Q26782984 | Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia |
| Q43447667 | Plasma progranulin levels in cortical dementia phenotypes with asymmetric perisylvian atrophy |
| Q47623958 | Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease |
| Q38501875 | Psychotic symptoms in frontotemporal dementia |
| Q38000119 | Recent advances in the genetics of the ALS-FTLD complex |
| Q36865695 | Schizophrenia or neurodegenerative disease prodrome? Outcome of a first psychotic episode in a 35-year-old woman |
| Q37730909 | TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions |
| Q38825197 | The clinical spectrum of sporadic and familial forms of frontotemporal dementia. |
| Q38222396 | The expanding universe of disorders of the basal ganglia |
| Q24615201 | The genetics and neuropathology of frontotemporal lobar degeneration |
| Q33778423 | The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics |
Search more.